Helius Medical initiates open-label study for registrational program in stroke

Helius Medical Technologies announced the initiation of an open-label study for its registrational program in stroke. The program was established based on encouraging early trial results as well as real-world evidence from Canada, where PoNS is already authorized for treatment of stroke, and aims to establish the effects of cranial-nerve non-invasive neuromodulation, delivered using PoNS Therapy, on gait and dynamic balance in chronic stroke survivors. Under the direction of Mark Bowden, PT, PhD, Brooks Rehabilitation will be the first site to enroll patients. Brooks Rehabilitation is already a participant site to the Company’s ongoing investigator-initiated, placebo-controlled study in stroke, led by Dr. Steven Kautz at the Medical University of South Carolina.